Partner with us
Studies
/
The Ketogenic Diet and Alzheimer's Disease
Review
2022

The Ketogenic Diet and Alzheimer's Disease

Key finding
The review found evidence that the ketogenic diet and exogenous ketone supplementation may provide treatment benefits in AD patients, but it is unclear which method is better and large long-term randomized trials are lacking.
What the study did

This review compares methods of inducing hyperketonemia, including the ketogenic diet and exogenous ketone supplementation, and their impact on Alzheimer's disease (AD) prevention and treatment. PubMed was searched for clinical trials and randomized controlled trials involving these approaches in AD patients, with MCI studies included for the combined approach section. It reports evidence that the ketogenic diet and exogenous ketones may provide treatment benefits, that it is unclear whether one method is better, and that most current studies are small, often uncontrolled, and short-term.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB